US Edition
BD Reports Results from AV Fistula Cohort of Lutonix AV Global Registry - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
BD Reports Results from AV Fistula Cohort of Lutonix AV Global Registry - Endovascular Today
May 21, 2025—BD (Becton, Dickinson and Company) announced post hoc analysis results from the arteriovenous (AV) fistula cohort of the Lutonix Global AV Registry. The registry assessed the safety and effectiveness of the company’s Lutonix 035 drug-coated balloon (DCB) in a real-world setting at 25 sites across Europe and Asia (N = 320). According to the company, the reported post hoc analysis findings from the AV fistula cohort (n = 124) included…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
